A unique circulating microRNA pairs signature serves as a superior tool for early diagnosis of pan-cancer

• Published in: Cancer letters Vol. 588; p. 216655
• Main Authors: Wu, Peng, Li, Dongyu, Zhang, Chaoqi, Dai, Bing, Tang, Xiaoya, Liu, Jingjing, Wu, Yue, Wang, Xingwu, Shen, Ao, Zhao, Jiapeng, Zi, Xiaohui, Li, Ruirui, Sun, Nan, He, Jie
• Format: Journal Article
• Language: English
• Published: Ireland Elsevier B.V 28.04.2024
• Subjects: Algorithms; Circulating MicroRNA - genetics; Early Diagnosis; Humans; MicroRNAs - genetics; MicroRNAs - metabolism; Neoplasms - diagnosis; Neoplasms - genetics
• ISSN: 0304-3835; 1872-7980
• DOI: 10.1016/j.canlet.2024.216655

Cancer remains a major burden globally and the critical role of early diagnosis is self-evident. Although various miRNA-based signatures have been developed in past decades, clinical utilization is limited due to a lack of precise cutoff value. Here, we innovatively developed a signature based on pairwise expression of miRNAs (miRPs) for pan-cancer diagnosis using machine learning approach. We analyzed miRNA spectrum of 15832 patients, who were divided into training, validation, test, and external test sets, with 13 different cancers from 10 cohorts. Five different machine-learning (ML) algorithms (XGBoost, SVM, RandomForest, LASSO, and Logistic) were adopted for signature construction. The best ML algorithm and the optimal number of miRPs included were identified using area under the curve (AUC) and youden index in validation set. The AUC of the best model was compared to previously published 25 signatures. Overall, Random Forest approach including 31 miRPs (31-miRP) was developed, proving highly efficient in cancer diagnosis across different datasets and cancer types (AUC range: 0.980–1.000). Regarding diagnosis of cancers at early stage, 31-miRP also exhibited high capacities, with AUC ranging from 0.961 to 0.998. Moreover, 31-miRP exhibited advantages in differentiating cancers from normal tissues (AUC range: 0.976–0.998) as well as differentiating cancers from corresponding benign lesions. Encouragingly, comparing to previously published 25 different signatures, 31-miRP also demonstrated clear advantages. In conclusion, 31-miRP acts as a powerful model for cancer diagnosis, characterized by high specificity and sensitivity as well as a clear cutoff value, thereby holding potential as a reliable tool for cancer diagnosis at early stage. •The study developed a miRP-based signature for diagnosis of pan-cancer.•Our signature exhibited good performance regarding diagnosis of various cancer.•Our signature is also capable of differentiating malignant from benign lesions.